The Hikma Board is recommending an interim dividend of 18 cents per share (approximately 13 pence per share) (H1 2020: 16 cents per share). The interim dividend will be paid on 20 September 2021 to eligible shareholders on the register at the close of business on 20 August 2021.
Other financial highlights include:
Core Group revenue grew 7% driven by a strong performance in Generics and Branded and the resilience of their Injectables business
Core operating profit grew 9% to $309 million and core operating margin reached 25%
Generated good cashflow from operating activities of $224 million. The reduction compared to the first half of 2020 reflects the timing of tax payments
Maintained low leverage with net debt to core EBITDA of 0.9x at 30 June 2021 (31 December 2020 0.9x)
